Anika Therapeutics ANIK Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Anika Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's quick ratio?
- Anika Therapeutics (ANIK) reported quick ratio of 3.4× in Q1 2026.
- How has Anika Therapeutics's quick ratio changed year-over-year?
- Anika Therapeutics's quick ratio decreased by 25.6% year-over-year, from 4.5× to 3.4×.
- What is the long-term trend for Anika Therapeutics's quick ratio?
- Over 5 years (2020 to 2025), Anika Therapeutics's quick ratio has grown at a 1.6% compound annual growth rate (CAGR), from 3.6× to 3.9×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.